Start-Up Execs On The Move, September 2015

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

Start-Up Execs

CRISPR Therapeutics

Michael Bruce, PhD

To:SVP, Program Portfolio & Alliance Mgmt. (August)

From:VP, Dev. Mgmt. & Bus. Ops., Worldwide R&D, Pfizer Inc.

Phone:[phone]

Samarth Kulkarni, PhD

To:CBO (August)

From:Partner, McKinsey & Co.

Phone:[phone]

Dimension Therapeutics Inc.

Jean M. Franchi

To:CFO (August)

From:CFO, Good Start Genetics

Phone:[phone]

Human Longevity Inc.

Mark A. Winham

To:COO (August)

From:COO, Millennium Health

Phone:[phone]

Metacrine Inc.

Neil McDonnell, PhD

To:CEO (August)

From:SVP, Therapeutic Area Lead, Cardiovascular & Metabolic Dis., Takeda Pharmaceuticals USA Inc.

Phone:[phone]

Scholar Rock Inc.

Paul D. Burgess

To:VP, Intellectual Property (July)

From:VP, Intellectual Property, Bind Therapeutics Inc.

Phone:[phone]

Spero Therapeutics LLC

Aileen Rubio, PhD

To:Head, Biology (July)

From:Dir., Infectious Diseases, Cubist Pharmaceuticals Inc.

Phone:[phone]

Turing Pharmaceuticals AG

Craig Rothenberg

To:Chief Communication Officer (July)

From:VP, Senior Communication Leader, Johnson & Johnson

Phone:[phone]

Start-Up Directors

Epic Sciences Inc.

Gregory C. Critchfield, MD

To:Director (July)

Phone:[phone]

KalVista Pharmaceuticals Ltd.

Rajeev Shah

To:Director (July)

Phone:[phone]

Loxo Oncology Inc.

Tim Mayleben

To:Director (July)

Phone:[phone]

Nimbus Therapeutics

Mark Iwicki

To:Director (July)

Phone:[phone]

George P. Vlasuk, PhD

To:Director (July)

Phone:[phone]

RaNA Therapeutics Inc.

Joshua Resnick, MD

To:Director (July)

Phone:[phone]

Rigontec GMBH

J. Donald deDethizy, PhD

To:Chairman (July)

Phone:[phone]

SentreHEART Inc.

Richard M. Ferrari

To:Director (August)

Phone:[phone]

SutroVax Inc.

Patrick Enright

To:Director (July)

Phone:[phone]

Tracy Saxton

To:Director (July)

Phone:[phone]

Velano Vascular Inc.

David Schlotterbeck

To:Director (August)

Phone:[phone]

Voyager Therapeutics Inc.

Michael Higgins

To:Director (July)

Phone:[phone]

Perry A. Karsen

To:Director (July)

Phone:[phone]

Start-Up Advisors

Alcyone Lifesciences Inc.

Olivier Danos, PhD

To:Scientific Advisor (July)

Phone:[phone]

Apellis Pharmaceuticals Inc.

Carl Atkinson, PhD

To:Scientific Advisor (July)

Phone:[phone]

Robert A. Brodsky, MD

To:Scientific Advisor (July)

Phone:[phone]

Gabriel J. Coscas, MD

To:Scientific Advisor (July)

Phone:[phone]

Peter Hillmen, MD, PhD

To:Scientific Advisor (July)

Phone:[phone]

Claudia Kemper, PhD

To:Scientific Advisor (July)

Phone:[phone]

Susan M. Lea, PhD

To:Scientific Advisor (July)

Phone:[phone]

Toby Maher, MD, PhD

To:Scientific Advisor (July)

Phone:[phone]

Philip J. Rosenfeld, MD, PhD

To:Scientific Advisor (July)

Phone:[phone]

Johanna M. Seddon, MD

To:Scientific Advisor (July)

Phone:[phone]

Dave Singh, MD

To:Scientific Advisor (July)

Phone:[phone]

Jason S. Slakter, MD

To:Scientific Advisor (July)

Phone:[phone]

Janet S. Sunness, MD

To:Scientific Advisor (July)

Phone:[phone]

Marsha Wills-Karp, PhD

To:Scientific Advisor (July)

Phone:[phone]

Mike Yeadon, PhD

To:Scientific Advisor (July)

Phone:[phone]

Start-Up Investors

Alpine BioVentures

Jay Venkatesan, MD

To:Managing Partner (July)

From:EVP, General Mgr., Oncothyreon Inc.

Phone:[phone]

Frazier Healthcare

Tadataka Yamada, PhD

To:Venture Partner (July)

From:Chief Medical & Scientific Officer, Takeda Pharmaceutical Co. Ltd.

Phone:[phone]

Outcome Capital

Craig A. Steger

To:Senior Advisor, Life Sciences (July)

From:Consultant, Forge 4ward

Phone:[phone]

Perella Weinberg Partners

Jason D. Forschler

To:Managing Director (July)

From:Exec. Dir., Healthcare Investment Banking, JP Morgan

Phone:[phone]

Promotions

CytomX Therapeutics Inc.

Bryan Irving, PhD

To:VP, Cancer Immunology (August)

From:Senior Dir., Cancer Immunology

Phone:[phone]

Debanjan Ray

To:SVP, Corp. Dev. & Strategy (August)

From:VP, Bus. Dev. & Alliance Mgmt.

Phone:[phone]